SIVA Polyclonal Antibody

This gene encodes a protein with an important role in the apoptotic (programmed cell death) pathway induced by the CD27 antigen, a member of the tumor necrosis factor receptor (TFNR) superfamily. The CD27 antigen cytoplasmic tail binds to the N-terminus of this protein. Two alternatively spliced transcript variants encoding distinct proteins have been described.

Introducing the SIVA Polyclonal Antibody, a cutting-edge biotechnological solution designed to revolutionize the field of immunology. This meticulously crafted antibody is meticulously engineered to target the SIVA protein, a key player in various cellular processes.

The SIVA Polyclonal Antibody boasts exceptional specificity and sensitivity, ensuring accurate and reliable results in a wide range of applications. Its high affinity for the SIVA protein enables precise detection and quantification, making it an invaluable tool for researchers and clinicians alike.

With its advanced formulation, the SIVA Polyclonal Antibody offers unparalleled versatility. It is compatible with various experimental techniques, including Western blotting, immunohistochemistry, and flow cytometry, facilitating comprehensive analysis of SIVA protein expression and localization.

Furthermore, the SIVA Polyclonal Antibody exhibits exceptional stability and reproducibility, guaranteeing consistent performance across multiple experiments. Its long shelf life and robust resistance to degradation ensure prolonged usability, minimizing the need for frequent reordering.

Manufactured under stringent quality control measures, the SIVA Polyclonal Antibody adheres to the highest industry standards. Each batch undergoes rigorous testing to ensure optimal performance, reliability, and consistency, providing researchers with utmost confidence in their experimental outcomes.

In summary, the SIVA Polyclonal Antibody represents a breakthrough in immunological research, offering unrivaled specificity, sensitivity, and versatility. With its exceptional stability and reproducibility, this antibody is poised to revolutionize the field, empowering researchers and clinicians to unravel the intricate mechanisms governed by the SIVA protein.